Going viral with cancer immunotherapy
Crossref DOI link: https://doi.org/10.1038/nrc3770
Published Online: 2014-07-03
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lichty, Brian D.
Breitbach, Caroline J.
Stojdl, David F.
Bell, John C.
Text and Data Mining valid from 2014-07-03
Version of Record valid from 2014-07-03
Article History
First Online: 3 July 2014
Competing interests
: Employment: SillaJen Biotherapeutics (C.J.B.). B.D.L., D.F.S. and J.C.B. declare no competing interests.